Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Jun. 30, 2021
Current assets:    
Cash and cash equivalents $ 150,410 $ 41,047
Prepaid expenses and other 1,694 946
Total current assets 152,104 41,993
Right-of-use assets 152 396
Deposits and other 148 191
Property and equipment, net 16 29
Total assets 152,420 42,609
Current liabilities:    
Accounts payable 1,132 1,035
Accrued liabilities:    
Insurance premiums 243 242
Compensation and benefits   77
Accrued clinical and other 979 349
Current portion of operating lease liabilities 108 265
Total current liabilities 2,462 1,968
Long term liabilities:    
Long term debt, net of discount   13,968
Operating lease liabilities, net of current portion 80 187
Embedded derivative liabilities 407 387
Total liabilities 2,949 16,510
Commitments and contingencies (Notes 3, 4, 7, 10 and 11)
Shareholders' equity:    
Preferred stock, $0.001 par value; 400 shares authorized; no shares issued and outstanding
Common stock, $0.001 par value; 100,000 and 40,000 shares authorized as of June 30, 2022, and 2021, respectively; 33,582 and 8,352 shares issued and outstanding as of June 30, 2022 and 2021, respectively 34 8
Additional paid-in capital 358,635 194,229
Accumulated deficit (209,198) (168,138)
Total shareholders' equity 149,471 26,099
Total liabilities and shareholders' equity $ 152,420 $ 42,609